文献速递消化内镜消化道肿瘤与早癌

新型结肠镜远端附件提高腺瘤检出率:一项多中心随机对照试验

Improved Adenoma Detection Rate Using a Novel Colonoscopic Distal Attachment: A Multicenter Randomized Controlled Trial.
PubMed 文献 · Am J Gastroenterol · 2024-04-25

该多中心随机对照试验纳入中国3个内镜中心的1179例常规结肠镜检查者,按1:1随机分为Embrella辅助结肠镜组(593例)和标准结肠镜组(586例)。结果显示,Embrella辅助结肠镜将总体腺瘤检出率从24.6%提高至34.2%(P<0.001),腺瘤/结肠镜从0.44提高至0.64(P=0.002),且未发生相关不良事件。

要点

  • Embrella辅助结肠镜较标准结肠镜显著提高总体腺瘤检出率(34.2% vs 24.6%,P<0.001)。
  • Embrella辅助结肠镜对<10 mm、无蒂及横结肠和左半结肠腺瘤的检出改善显著。
  • Embrella辅助结肠镜平均检查时间更短(6.52 vs 6.68分钟,P=0.046),未发生相关不良事件。

核心结论

  • 与标准结肠镜相比,Embrella辅助结肠镜显著提高腺瘤检出率和腺瘤/结肠镜,尤其对<10 mm、无蒂及横结肠和左半结肠腺瘤。

研究设计与样本

  • 多中心随机对照试验,纳入中国3个内镜中心所有连续接受常规结肠镜检查的参与者,按1:1随机分为Embrella辅助结肠镜组(n=593)和标准结肠镜组(n=586)。

主要发现

  • Embrella辅助结肠镜组总体腺瘤检出率为34.2%,标准结肠镜组为24.6%(P<0.001)。
  • Embrella辅助结肠镜组腺瘤/结肠镜为0.64,标准结肠镜组为0.44(P=0.002)。
  • 亚组分析显示,Embrella辅助结肠镜组5-9 mm腺瘤检出率为13.8%,标准结肠镜组为8.5%(P=0.004);<5 mm腺瘤检出率为27.0% vs 17.2%(P<0.001)。
  • Embrella辅助结肠镜组无蒂腺瘤检出率为26.6%,标准结肠镜组为18.8%(P<0.001);横结肠腺瘤检出率为10.8% vs 6.1%(P=0.004);左半结肠腺瘤检出率为21.6% vs 13.7%(P<0.001)。
  • Embrella辅助结肠镜组平均检查时间为6.52分钟,标准结肠镜组为6.68分钟(P=0.046);参与者疼痛评分无显著影响(P=0.377);未发生Embrella相关不良事件。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: To evaluate the effect of Embrella, a novel-designed colonoscopic distal attachment, on adenoma detection rate (ADR) and adenoma per colonoscopy (APC), compared with standard colonoscopy in routine practice. METHODS: All consecutive participants who underwent routine colonoscopic examinations at 3 endoscopy centers in China were enrolled. Participants were randomly assigned in a 1:1 ratio to the Embrella-assisted colonoscopy (EAC) or standard colonoscopy (SC) groups. ADR, APC, inspection time, pain scores, and adverse events were recorded. RESULTS: Overall, 1,179 participants were randomized into the EAC (n = 593) and SC groups (n = 586). EAC increased the overall ADR from 24.6% to 34.2% ( P < 0.001) and improved APC from 0.44 to 0.64 ( P = 0.002). Subgroup analyses indicated that EAC significantly improved ADR for adenomas < 10 mm (13.8% vs 8.5%, P = 0.004 for 5-9 mm and 27.0% vs 17.2%, P < 0.001 for < 5 mm), nonpedunculated adenomas (26.6% vs 18.8%, P < 0.001), and adenomas in the transverse (10.8% vs 6.1%, P = 0.004) and left colon (21.6% vs 13.7%, P < 0.001). APC in the subgroup analyses was consistent with ADR. The mean inspection time was shorter with EAC (6.52 vs 6.68 minutes, P = 0.046), with no significant impact on participants' pain scores ( P = 0.377). Moreover, no EAC-related adverse events occurred. DISCUSSION: EAC significantly increased ADR and APC compared with SC, particularly for adenomas <10 mm, nonpedunculated adenomas, and adenomas in the transverse and left colon.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Guo R, Wang J, Min L, et al. Improved Adenoma Detection Rate Using a Novel Colonoscopic Distal Attachment: A Multicenter Randomized Controlled Trial. Am J Gastroenterol. 2024. PMID: 38661152. doi:10.14309/ajg.0000000000002829

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。